Crossmark Global Holdings Inc. Invests $645,000 in Masimo Corporation (MASI) Stock

Crossmark Global Holdings Inc. acquired a new stake in Masimo Corporation (NASDAQ:MASI) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,456 shares of the medical equipment provider’s stock, valued at approximately $645,000.

A number of other large investors have also recently bought and sold shares of MASI. BlackRock Inc. boosted its position in Masimo Corporation by 7.5% in the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after buying an additional 550,995 shares during the last quarter. Koch Industries Inc. boosted its position in Masimo Corporation by 5,053.7% in the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock valued at $439,000 after buying an additional 435,325 shares during the last quarter. Acadian Asset Management LLC boosted its position in Masimo Corporation by 28.0% in the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock valued at $163,356,000 after buying an additional 392,410 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Masimo Corporation by 76.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock valued at $73,191,000 after buying an additional 347,360 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in Masimo Corporation by 6.9% in the 2nd quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock valued at $450,036,000 after buying an additional 318,060 shares during the last quarter. 84.94% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/16/crossmark-global-holdings-inc-invests-645000-in-masimo-corporation-masi-stock.html.

A number of equities analysts have weighed in on MASI shares. BidaskClub cut shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Stifel Nicolaus restated a “buy” rating and issued a $108.00 target price on shares of Masimo Corporation in a research note on Friday, November 3rd. Zacks Investment Research upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a research note on Thursday, November 2nd. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Monday, August 14th. Finally, Roth Capital upped their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $97.17.

Shares of Masimo Corporation (MASI) opened at $86.37 on Thursday. The stock has a market cap of $4,465.94, a PE ratio of 33.12, a PEG ratio of 2.91 and a beta of 0.75. Masimo Corporation has a 12 month low of $60.31 and a 12 month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. The business had revenue of $193.69 million for the quarter, compared to analyst estimates of $189.01 million. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The company’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.52 EPS. research analysts forecast that Masimo Corporation will post 2.95 earnings per share for the current year.

In related news, EVP Yongsam Lee sold 13,976 shares of the stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $89.43, for a total transaction of $1,249,873.68. Following the sale, the executive vice president now owns 74,000 shares in the company, valued at $6,617,820. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Steven Barker sold 10,000 shares of the stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the sale, the director now owns 73,249 shares in the company, valued at approximately $6,592,410. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,976 shares of company stock worth $2,599,324. 16.60% of the stock is owned by company insiders.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply